Despite advances in medical therapy to decrease morbidity and mortality in heart failure with reduced ejection fraction, age-adjusted mortality rates in 2021 were higher than in 1999, and rates of ...

Result from H2 Analytics is the highest concentration Ocemida has recorded across its product line, and is published in ...

Dexamphetamine and methylphenidate were equally effective in treating the core features of ADHD in children, but participants ...

Good day, and welcome to the Viking Therapeutics Second Quarter 2026 Financial Results Conference Call. [Operator Instructions] And as a reminder, this conference call is being recorded today, July 29 ...

Morocco Strategic Minerals Corporation (TSXV: MCC) ("Morocco Strategic Minerals", "MCC" or the "Company") is pleased to ...

Mitapivat (PYRUKYND® and AQVESME™) delivered worldwide net revenues of $44.7 million in the second quarter of 2026, compared to $12.5 million in ...

Good morning, and welcome to Agios Pharmaceuticals Second Quarter 2026 Conference Call. [Operator Instructions] Please be advised that this call is being recorded at Agios' request. I would now like ...

Morocco Strategic Minerals Corporation (TSXV: MCC) ("Morocco Strategic Minerals", "MCC" or the "Company") is pleased to ...

Morocco Strategic Minerals Corporation (TSXV: MCC) ("Morocco Strategic Minerals", "MCC" or the "Company") is pleased to ...

Xcopri (cenobamate) is a brand-name drug prescribed for focal onset seizures (also called partial onset seizures) in adults. Xcopri comes as an oral tablet that’s typically taken once per day. The ...

Mitapivat (PYRUKYND and AQVESME) delivered worldwide net revenues of $44.7 million in the second quarter of 2026, compared to $12.5 million in the second quarter of 2025Strong U.S. commercial launch ...

With dozens of telehealth platforms now competing for patients looking to access GLP-1 weight loss medications, choosing the right provider comes down to a handful of practical factors: what ...